DXCM

DexCom, Inc.

76.56
USD
2.72%
76.56
USD
2.72%
67.11 659.45
52 weeks
52 weeks

Mkt Cap 7.21B

Shares Out 96.75M

Chat
Send me real-time posts from this site at my email

Health Care Sector Update for 05/24/2022: INMB.PODD,DXCM,CUTR

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both were down 0.6%. The Nasdaq Biotechnology index was sinking 1.8%. In company news, INmune Bio (INMB) Tuesday was plunging almost 29% after saying the US Food and Drug Administration late last week placed a clinical hold on phase II testing of the company's XPro1595 drug candidate and requested additional information on the chemistry, manufacturing and controls for the prospective treatment for Alzheimer's disease. Cutera (CUTR) declined almost 14% after the medical device company Tuesday disclosed plans for a $200 million private placement of convertible senior notes due 2028. Insulet (PODD) rose 5.1% amid reports Dexcom (DXCM) is pursuing a potential acquisition of the medical device company. A deal could be reached "in the coming weeks," unnamed sources told Bloomberg, although they also cautioned the talks could still fall apart. DexCom shares were dropping over 12% this afternoon. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue